Laboratories seeking to buy Semax and Selank require analytical-grade regulatory peptide analogs backed by stringent quality verification. PX1 Research provides USA-manufactured ACTH(4-10) and tuftsin-derived sequence variants featuring lot-specific HPLC purity reports, mass spectrometry identification, and endotoxin quantification for rigorous in vitro and animal models.
Laboratories seeking to buy Semax and Selank require analytical-grade regulatory peptide analogs backed by stringent quality verification. PX1 Research provides USA-manufactured ACTH(4-10) and tuftsin-derived sequence variants featuring lot-specific HPLC purity reports, mass spectrometry identification, and endotoxin quantification for rigorous in vitro and animal models.
When purchasing synthetic regulatory peptides for scientific investigation, researchers must ensure their samples meet rigorous chemical standards. Semax and Selank are synthetic heptapeptides derived from endogenous peptide fragments—specifically adrenocorticotropic hormone (ACTH) and tuftsin, respectively. Both compounds are widely evaluated in molecular neurobiology, neuropharmacology, and cellular stress research.
To maintain experimental reproducibility, investigators require high-purity reagents free of truncated sequences, residual solvents, or bacterial endotoxins. PX1 Research serves academic, pharmaceutical, and institutional facilities by supplying reference-standard materials. When researchers buy semax selank compounds from PX1 Research, every batch undergoes comprehensive quality control protocols to ensure precise sequence integrity and high stability across diverse experimental conditions.
Semax (Met-Glu-His-Phe-Pro-Gly-Pro) was designed as a stabilized analog of the N-terminal fragment ACTH(4-10). The native ACTH(4-10) core sequence retains neurotropic activity but exhibits a extremely short enzymatic half-life in biological substrates. To address this rapid degradation, bio-engineers appended a C-terminal Pro-Gly-Pro tripeptide motif, dramatically enhancing resistance to carboxypeptidases and peptidases.
Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) shares a similar stabilization methodology but originates from a different endogenous precursor. It incorporates the tetrapeptide tuftsin (Thr-Lys-Pro-Arg), an endogenous immunomodulatory fragment, fused to the identical C-terminal Pro-Gly-Pro motif. Exploring these structural modifications within our wider catalog of research peptides allows investigators to evaluate how terminal proline-glycine sequences affect enzyme kinetics, structural folding, and receptor interaction profiles.
In preclinical literature, both Semax and Selank are studied for their capacity to modulate gene expression related to neurotrophin signaling pathways. Preclinical studies suggest that exposure to Semax elevates Brain-Derived Neurotrophic Factor (BDNF) mRNA transcription and protein levels in rodent hippocampal and cortical tissue preparations. This mechanism is central to ongoing research examining synaptic plasticity, axonal growth, and cellular resilience under metabolic stress.
In vitro data indicate that both peptides also influence Nerve Growth Factor (NGF) and TrkB receptor signaling cascades without directly activating classical steroidogenic ACTH receptors. Furthermore, research demonstrates that Selank interacts with monoaminergic systems, altering serotonin metabolism and dopamine turnover in rodent models of neurological stress. Investigators interested in mapping these pathways often access our expanded neurological research peptides repository for comparative pathway analyses.
Although Semax and Selank share the C-terminal Pro-Gly-Pro stabilizing sequence, their N-terminal cores drive distinct cellular and gene-regulatory profiles in experimental settings. Semax, derived from ACTH(4-10), demonstrates pronounced engagement with neurotrophic pathways and vascular endothelial growth factor (VEGF) gene expression during hypoxic cellular stress assays. Conversely, Selank, derived from tuftsin, exhibits marked effects on inflammatory cytokine gene expression (such as IL-6) and GABAergic neurotransmission markers in preclinical models.
When designing comparative assays across regulatory peptides, researchers often contrast these ACTH and tuftsin derivatives with other synthetic sequence modulators. For instance, investigators evaluating cellular repair and neuroprotective signaling pathways frequently contrast the activity of the Selank peptide and Semax research compound alongside broader tissue-modulating agents such as BPC-157 or synthetic cognitive research molecules like Dihexa.
Evaluating chemical purity is a prerequisite for generating reliable quantitative assay data. Impurities such as failure sequences, D-amino acid enantiomers, or residual trifluoroacetate (TFA) salts can distort receptor binding kinetics and cell culture viability metrics. PX1 Research enforces strict quality assurance protocols to guarantee that every lot meets specified purity baselines.
Our analytical standards mandate reverse-phase high-performance liquid chromatography (RP-HPLC) to verify chemical purity exceeding 99.0%, accompanied by electrospray ionization mass spectrometry (ESI-MS) to confirm exact molecular weight. Additionally, because bacterial lipopolysaccharides induce severe inflammatory signaling in vitro, all lots undergo Limulus Amebocyte Lysate (LAL) testing to ensure endotoxin levels remain strictly below <0.01 EU/mg. Researchers can review detailed testing methodologies through our laboratory research hub.
Proper handling and storage protocols are vital to preserving peptide sequence stability and preventing aggregation in laboratory environments. Semax and Selank are supplied as lyophilized (freeze-dried) cakes or powders, optimized for long-term thermodynamic stability under inert atmosphere packaging.
For laboratory reconstitution, researchers typically utilize sterile, endotoxin-free water or phosphate-buffered saline (PBS, pH 7.4), depending on assay requirements. Reconstitution should involve gentle swirling rather than vigorous vortexing to avoid mechanical shear stress on the peptide backbone. Reconstituted solutions intended for short-term use should be stored at 2°C to 8°C, while long-term stock aliquots require storage at -20°C or -80°C to eliminate enzymatic degradation and chemical hydrolysis.
In experimental models of ischemia, hypoxia, and oxidative stress, ACTH(4-10) regulatory peptide analogs exhibit notable protective signaling profiles. Preclinical animal studies indicate that Semax rapidly alters transcriptomic profiles in brain tissue following vascular occlusion, upregulating genes associated with neurotrophic signaling, extracellular matrix remodeling, and anti-inflammatory pathways.
Similarly, in vitro studies evaluating Selank reveal modulation of gene networks involved in immunomodulation and neurotransmitter receptor regulation. Scientists researching broad-spectrum stress responses, neuroplasticity, or gene expression profiling can examine lot specifications or request bulk configurations through our dedicated bulk lab purchasing program.
PX1 Research is dedicated to supporting scientific discovery by maintaining standard-setting manufacturing and distribution infrastructure. All peptides available in our catalog are manufactured in USA-based, GMP-compliant facilities operating under ISO 9001 and ISO 17025 quality management standards.
To prevent batch-to-batch variability and guarantee analytical integrity, every product lot is linked to an independent, lot-specific Certificate of Analysis (COA). PX1 Research operates dual fulfillment nodes located in California and Arizona, enabling same-day dispatch for orders placed Monday through Friday prior to cut-off times. This robust logistical infrastructure ensures high reagent integrity from synthesis to laboratory receipt.
What is the primary difference between Semax and Selank in research settings?
Semax is an ACTH(4-10) heptapeptide derivative primarily investigated for neurotrophic signaling and BDNF/NGF upregulation. Selank is a tuftsin-derived heptapeptide analog studied for its effects on immunomodulatory gene expression, GABAergic system modulation, and serotonin metabolism in preclinical models.
What analytical documentation is included when purchasing Semax and Selank from PX1 Research?
Every lot of Semax and Selank includes a third-party Certificate of Analysis (COA) containing Reverse-Phase HPLC chromatograms (confirming >99% purity), Mass Spectrometry (MS) spectra (confirming molecular mass), and quantitative LAL endotoxin testing results.
How should lyophilized Semax and Selank be stored upon arrival?
Lyophilized peptide vials should be stored in a freezer at -20°C or -80°C for long-term stability. Storage at 2°C to 8°C is acceptable for short-term handling prior to reconstitution, provided the container remains sealed against moisture.
What are the recommended solvents for laboratory reconstitution?
Researchers typically reconstitute lyophilized Semax and Selank using sterile, endotoxin-free bacteriostatic water, sterile 0.9% sodium chloride, or laboratory-grade phosphate-buffered saline (PBS, pH 7.4) tailored to the specific in vitro or cellular assay protocol.
What are the endotoxin limits for PX1 Research compounds?
PX1 Research enforces an industry-leading endotoxin limit of <0.01 EU/mg across regulatory peptide lots, verified via Limulus Amebocyte Lysate (LAL) testing to prevent confounding biological responses in immune or cell culture assays.
Are Semax and Selank intended for human administration?
No. All products supplied by PX1 Research are strictly designated for laboratory research use only by qualified academic, institutional, or corporate researchers. They are not intended for human or veterinary clinical use, therapeutic administration, or diagnostic procedures.
Where are PX1 Research peptides manufactured and shipped from?
PX1 Research peptides are USA-manufactured in GMP-compliant facilities. Orders are fulfilled directly from our dual distribution centers located in California and Arizona, offering same-day shipping for orders placed Monday through Friday before cut-off.
Can institutions purchase Semax and Selank in bulk for high-throughput screening?
Yes. Institutional researchers and laboratory directors can set up lab accounts and place volume purchases directly through our wholesale program to support large-scale preclinical studies.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.